ArticleJCEM case reports2025
Severe Menorrhagia as the Initial Presentation of Myxedema Coma With Pericardial Effusion.
Article in JCEM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myxedema coma is a rare but serious complication of severe hypothyroidism, often presenting without coma, complicating diagnosis. Cardiovascular and hematologic abnormalities can predominate, including pericardial effusion and bleeding diathesis. We describe a 38-year-old woman with no thyroid history who presented with significant menorrhagia and acute anemia. She had fatigue, cold intolerance, and intermittent bradycardia but no hypothermia or altered mental status. Evaluation revealed a prolonged activated partial thromboplastin time and a large pericardial effusion with early tamponade, requiring pericardiocentesis. Thyroid testing showed profound hypothyroidism. Her presentation suggested myxedema coma despite preserved consciousness. She was treated with intravenous levothyroxine, hydrocortisone, red blood cell transfusion, and progestin therapy, resulting in complete resolution of the effusion and stabilization of hemoglobin. She remained asymptomatic on oral levothyroxine at 2-month follow-up. This case highlights an unusual presentation of new-onset hypothyroidism manifesting as menorrhagia with coagulopathy and pericardial effusion. The reversible nature of both the hematologic and cardiovascular findings underscores the importance of early recognition and treatment. Clinicians should consider thyroid dysfunction in unexplained heavy menstrual bleeding or severe anemia, particularly when systemic features suggest endocrine involvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.